MYOF
protein-codingmyoferlin, the group of Ferlin family
Gene summary
Mutations in dysferlin, a protein associated with the plasma membrane, can cause muscle weakness that affects both proximal and distal muscles. The protein encoded by this gene is a type II membrane protein that is structurally similar to dysferlin. It is a member of the ferlin family and associates with both plasma and nuclear membranes. The protein contains C2 domains that play a role in calcium-mediated membrane fusion events, suggesting that it may be involved in membrane regeneration and repair. Two transcript variants encoding different isoforms have been found for this gene. Other possible variants have been detected, but their full-length nature has not been determined. [provided by RefSeq, Dec 2008]
- FER1L3
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~175.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: Unknown
Disease ID:MONDO:0025713
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AD
Disease ID:MONDO:0025713
Submitter: PanelApp Australia
Clinical Genomic Database (CGD)
Manifestation: Allergy/Immunology/Infectious
Intervention: Allergy/Immunology/Infectious
Rationale: The condition can involved episodes of angioedema, and medical management may be beneficial
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to MYOF variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_013451.4. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 26 | 3 | 34 | ||
| missense | 1 | 1 | 326 | 22 | 5 | 355 |
| nonsense | 5 | 1 | 6 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 12 | 12 | ||||
| Total | 1 | 1 | 349 | 49 | 8 | 408 |
Highest pathogenic variant AF is 0.000016728438
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_038479.1 | 54 | MANE Select | |
| Ensembl | ENSP00000352208.4 | 54 | MANE Select | |
| RefSeq | NP_579899.1 | 53 | Standard | |
| Ensembl | ENSP00000351094.5 | 53 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Aryl Hydrocarbon Receptor Pathway
- Nuclear Receptors Meta-Pathway
- Hepatitis C and Hepatocellular Carcinoma
- Signaling events mediated by VEGFR1 and VEGFR2
Biological Process
- plasma membrane repair
- glycerol metabolic process
- muscle contraction
- myoblast fusion
- blood circulation
Molecular Function
- protein binding
- phospholipid binding
Cellular Component
- nuclear envelope
- plasma membrane
- caveola
- integral component of membrane
- cytoplasmic vesicle membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000359263
- Coding exons
- 54
- Length
- 175889
- Individuals with no LoFs
- 124357
- Homozygous LoFs
- 2
- Heterozygous LoFs
- 690
- Defined
- 125049
- p
- 0.00277
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.112 | 1156 | 1.17e+3 | 0.991 | 0.0000666 | 13537 |
| Missense (PolyPhen) | 439 | 456.57 | 0.96152 | 5398 | ||
| Synonymous | 0.279 | 430 | 437 | 0.983 | 0.0000265 | 3880 |
| Loss of Function | 2.49 | 101 | 132 | 0.766 | 0.00000743 | 1448 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.0037 | 0.0037 | notable |
| Latino/Admixed American | 0.0031 | 0.0030 | notable |
| Ashkenazi Jewish | 0.0046 | 0.0046 | notable |
| East Asian | 0.0027 | 0.0027 | notable |
| Finnish | 0.0011 | 0.0011 | notable |
| European (Non-Finnish) | 0.0022 | 0.0022 | notable |
| South Asian | 0.0048 | 0.0048 | notable |
| Other | 0.0020 | 0.0020 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: Calcium/phospholipid-binding protein that plays a role in the plasmalemma repair mechanism of endothelial cells that permits rapid resealing of membranes disrupted by mechanical stress. Involved in endocytic recycling. Implicated in VEGF signal transduction by regulating the levels of the receptor KDR (By similarity). {ECO:0000250}.;
Recessive Scores
- pRec
- 0.134
Intolerance Scores
- LoFtool
- 0.0903
- RVIS EVS
- -0.44
- RVIS percentile EVS
- 24.68
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- E
- Indispensability score
- 0.517
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |